Robert Nelsen
QuietNamed in filings at ARCH Venture PartnersOn the current fund
- Board seats filed
- 23
Named in filings at ARCH Venture PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Seaport Therapeutics | Biotech & pharma | October 2024 | Capra CLO Founders, Sofinnova Venture Partners |
| RIPPL Care | Healthcare services | October 2024 | General Catalyst |
| Medical Creations | Education | June 2021 | None on file |
| National Resilience | Biotech & pharma | October 2020 | None on file |
| Neumora Therapeutics | Biotech & pharma | September 2020 | None on file |
| Nutcracker Therapeutics | Biotech & pharma | May 2020 | None on file |
| Insitro | Biotech & pharma | March 2020 | None on file |
| Apex Neuro Holdings | AI & machine learning | October 2019 | None on file |
| Sana Biotechnology | Biotech & pharma | October 2018 | None on file |
| Vir Biotechnology | Biotech & pharma | June 2018 | None on file |
| Beam Therapeutics | Biotech & pharma | February 2018 | Aditum Bio |
| Gossamer Bio | Biotech & pharma | January 2018 | None on file |
| Arivale | Digital health | May 2017 | Maveron |
| Grail | Biotech & pharma | February 2017 | None on file |
| Unity Biotechnology | Biotech & pharma | October 2016 | None on file |
| SAPPHIRE ENERGY | Climate & energy | December 2015 | None on file |
| Sienna Biopharmaceuticals | Biotech & pharma | October 2015 | None on file |
| Syros Pharmaceuticals | Biotech & pharma | October 2014 | Polaris Partners, Samsara Biocapital |
| Faraday Pharmaceuticals | Biotech & pharma | July 2014 | Polaris Partners |
| Juno Therapeutics | Biotech & pharma | April 2014 | None on file |
| Bellerophon Therapeutics | Biotech & pharma | February 2014 | None on file |
| Sage Therapeutics | Biotech & pharma | January 2014 | None on file |
| NeurogesX | Biotech & pharma | February 2012 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Robert Nelsen on the board, based on 23 filed seats with a verified or cited source.